These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Salvage therapy with anti-IL-2 receptor antibodies in high-risk kidney transplant patients]. Carl S, Wiesel M, Deiss JM, Daniel V, Opelz G, Staehler G. J Urol (Paris); 1997 Apr; 103(1-2):7-9. PubMed ID: 9765770 [No Abstract] [Full Text] [Related]
7. Phenotypic and functional analysis of graft-infiltrating cells following therapy with anti-interleukin-2 receptor monoclonal antibody and cyclosporine A in the rat. Sido B, Morris PJ, Dallman M. Transplant Proc; 1992 Dec; 24(6):2549-50. PubMed ID: 1465862 [No Abstract] [Full Text] [Related]
11. Immunosuppression in small bowel transplantation--treatment with a monoclonal IL-2 receptor antibody (NDS 61). Schweizer E, Papachrysanthou A, Faendrich F, Deltz E, Schroeder P. Transplant Proc; 1994 Dec; 26(6):3142-3. PubMed ID: 7998095 [No Abstract] [Full Text] [Related]
19. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process. Reinke P, Kern F, Fietze E, Döcke WD, Ewert R, Emmrich F, Volk HD. Transplant Proc; 1995 Feb; 27(1):859-62. PubMed ID: 7879207 [No Abstract] [Full Text] [Related]